Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2008
Date: 2009-09-24
Institutions: Standing Committee of the EFTA States
Subjects: EFTA countries, European Economic Area, market approval, marketing, medicinal product








C_2009230EN.01001801.xml










24.9.2009   


EN


Official Journal of the European Union


C 230/18





Medicinal products — List of marketing authorisations granted by the EEA EFTA States for the second half of 2008
2009/C 230/08

Subcommittee I on the free movement of goods


To be noted by the EEA Joint Committee

With reference to EEA Joint Committee Decision No 74/1999 of 28 May 1999, the EEA Joint Committee is invited to note the following lists concerning marketing authorisations for medicinal products for the period 1 July-31 December 2008, at their meeting on 24 April 2009:







Annex I



List of new marketing authorisations





Annex II



List of renewed marketing authorisations





Annex III



List of extended marketing authorisations





Annex IV



List of withdrawn marketing authorisations





Annex V



List of suspended marketing authorisations






ANNEX I

List of new marketing authorisations

The following marketing authorisations have been granted in the EEA EFTA States during the period 1 July-31 December 2008:








EU-Number


Product


Country


Date of authorisation




EU/1/06/380/001


Prezista


Liechtenstein


31.12.2008




EU/1/08/444/001/NO-008/NO


Ratiograstim


Norway


2.10.2008




EU/1/08/444/001-008


Ratiograstim


Liechtenstein


31.10.2008




EU/1/08/444/001-008/IS


Ratiograstim


Iceland


24.10.2008




EU/1/08/445/001/NO-008/NO


Tevagrastim


Norway


8.10.2008




EU/1/08/445/001-008


Tevagrastim


Liechtenstein


31.10.2008




EU/1/08/445/001-008/IS


Tevagrastim


Iceland


24.10.2008




EU/1/08/446/001/NO-002/NO


Bridion


Norway


12.9.2008




EU/1/08/449/001/NO-008/NO


Filgrastim


Norway


8.10.2008




EU/1/08/449/001-008


Filgrastim Ratiopharm


Liechtenstein


31.10.2008




EU/1/08/449/001-008/IS


Filgrastim Ratiopharm


Iceland


24.10.2008




EU/1/08/450/001/NO-008/NO


Biograstim


Norway


2.10.2008




EU/1/08/450/001-008


Biograstim


Liechtenstein


31.10.2008




EU/1/08/450/001-008/IS


Biograstim


Iceland


24.10.2008




EU/1/08/452/001/NO


Pandemrix


Norway


6.8.2008




EU/1/08/453/001/NO


Prepandemrix


Norway


18.9.2008




EU/1/08/455/001/NO-014/NO


Janumet


Norway


5.8.2008




EU/1/08/455/001-014


Janumet


Liechtenstein


31.8.2008




EU/1/08/455/001-014/IS


Janumet


Iceland


5.9.2008




EU/1/08/456/001/NO-014/NO


Velmetia


Norway


5.8.2008




EU/1/08/456/001-014


Velmetia


Liechtenstein


31.8.2008




EU/1/08/456/001-014/IS


Velmetia


Iceland


5.9.2008




EU/1/08/457/001/NO-014/NO


Efficib


Norway


5.8.2008




EU/1/08/457/001-014


Efficib


Liechtenstein


31.8.2008




EU/1/08/457/001-014/IS


Efficib


Iceland


5.9.2008




EU/1/08/458/001/NO-011/NO


Trevaclyn


Norway


29.7.2008




EU/1/08/458/001-011


Trevaclyn


Liechtenstein


31.8.2008




EU/1/08/458/001-011/IS


Trevaclyn


Iceland


25.7.2008




EU/1/08/459/001/NO-011/NO


Tredaptive


Norway


29.7.2008




EU/1/08/459/001-011


Tredaptive


Liechtenstein


31.8.2008




EU/1/08/459/001-011/IS


Tredaptive


Iceland


25.7.2008




EU/1/08/460/001/NO-011/NO


Pelzont


Norway


29.7.2008




EU/1/08/460/001-011


Pelzont


Liechtenstein


31.8.2008




EU/1/08/460/001-011/IS


Pelzont


Iceland


25.7.2008




EU/1/08/461/001


Firazyr (orphan drug)


Liechtenstein


31.8.2008




EU/1/08/461/001/IS


Firazyr


Iceland


25.7.2008




EU/1/08/461/001/NO


Firazyr


Norway


25.8.2008




EU/1/08/462/001-006/IS


Latixa


Iceland


28.7.2008




EU/1/08/463/001/NO-003/NO


Relistor


Norway


11.7.2008




EU/1/08/463/001-003


Relistor


Liechtenstein


31.8.2008




EU/1/08/463/001-003/IS


Relistor


Iceland


24.7.2008




EU/1/08/464/001/NO-017/NO


Clopidogrel BMS


Norway


7.8.2008




EU/1/08/464/001-017


Clopidogrel BMS


Liechtenstein


31.8.2008




EU/1/08/464/001-017/IS


Clopidogrel BMS


Iceland


22.9.2008




EU/1/08/465/001/NO-017/NO


Clopidogrel Winthrop


Norway


7.8.2008




EU/1/08/465/001-017


Clopidogrel Winthrop


Liechtenstein


31.8.2008




EU/1/08/465/001-017/IS


Clopidogrel Winthrop


Iceland


12.9.2008




EU/1/08/466/001-002


Bridion


Liechtenstein


31.8.2008




EU/1/08/466/001-002/IS


Bridion


Iceland


4.9.2008




EU/1/08/467/001


Doribax


Liechtenstein


31.8.2008




EU/1/08/467/001/IS


Doribax


Iceland


8.9.2008




EU/1/08/467/001/NO


Doribax


Norway


1.9.2008




EU/1/08/468/001


Intelence


Liechtenstein


31.10.2008




EU/1/08/468/001/IS


Intelence


Iceland


26.9.2008




EU/1/08/468/001/NO


Intelence


Norway


18.9.2008




EU/1/08/468/001/NO-025/NO


Oprymea


Norway


9.10.2008




EU/1/08/469/001-025


Oprymea


Liechtenstein


31.10.2008




EU/1/08/469/001-025/IS


Oprymea


Iceland


27.10.2008




EU/1/08/470/001/NO-016/NO


Vimpat


Norway


22.9.2008




EU/1/08/470/001-015/IS


Vimpat


Iceland


10.9.2008




EU/1/08/470/001-016


Vimpat


Liechtenstein


31.10.2008




EU/1/08/471/001/NO-012/NO


Duloxetine Boehringer Ingelheim


Norway


29.10.2008




EU/1/08/471/001-012


Duloxetine Boehringer Ingelheim


Liechtenstein


31.10.2008




EU/1/08/471/001-012/IS


Duloxetine Boehringer Ingelheim


Iceland


7.11.2008




EU/1/08/472/001/NO-008/NO


Xarelto


Norway


9.10.2008




EU/1/08/472/001-008


Xarelto


Liechtenstein


31.10.2008




EU/1/08/472/001-008/IS


Xarelto


Iceland


15.10.2008




EU/1/08/473/001/NO-003/NO


Evicel


Norway


28.10.2008




EU/1/08/473/001-003


Evicel


Liechtenstein


31.10.2008




EU/1/08/473/001-003/IS


Evicel


Iceland


17.11.2008




EU/1/08/474/001-003


Fluticasone furoate GSK


Liechtenstein


31.10.2008




EU/1/08/475/001/NO-034/NO


Olanzapine Mylan


Norway


29.10.2008




EU/1/08/475/001-034


Olanzapine Mylan


Liechtenstein


31.10.2008




EU/1/08/475/001-034/IS


Olanzapine Mylan


Iceland


21.11.2008




EU/1/08/476/001/NO-004/NO


Tadalafil


Norway


23.10.2008




EU/1/08/476/001-004


Tadalafil Lilly


Liechtenstein


31.10.2008




EU/1/08/477/001


Ceplene (orphan)


Liechtenstein


31.10.2008




EU/1/08/477/001/IS


Ceplene


Iceland


19.11.2008




EU/1/08/478/001


Prepandemic influenza vaccine (H5N1)


Liechtenstein


31.10.2008




EU/1/08/478/001/IS


Prepandemic influenza vaccine (H5N1)


Iceland


24.10.2008




EU/1/08/478/001/NO


Prepandemic influenza vaccine


Norway


4.12.2008




EU/1/08/479/001/NO-003/NO


Zypadhera


Norway


16.12.2008




EU/1/08/479/001-003


Zypadhera


Liechtenstein


31.12.2008




EU/1/08/479/001-003/IS


Zypadhera


Iceland


16.12.2008




EU/1/08/480/001-018


Irbesartan Krka


Liechtenstein


31.12.2008




EU/1/08/481/001-003


Kuvan (orphan drug)


Liechtenstein


31.12.2008




EU/1/08/482/001-002


Azarga


Liechtenstein


31.12.2008




EU/1/08/483/001-018


Zomarist


Liechtenstein


31.12.2008




EU/1/08/484/001-018


Vildagliptin


Liechtenstein


31.12.2008




EU/1/08/485/001/NO-011/NO


Jalra


Norway


4.12.2008




EU/1/08/485/001-011


Jalra


Liechtenstein


31.12.2008




EU/1/08/485/001-011/IS


Jalra


Iceland


16.12.2008




EU/1/08/486/001/NO-011/NO


Xiliarx


Norway


4.12.2008




EU/1/08/486/001-011


Xiliarx


Liechtenstein


31.12.2008




EU/1/08/486/001-011/IS


Xiliarx


Iceland


16.12.2008




EU/1/08477/001/NO


Ceplene


Norway


28.10.2008




EU/2/08/080/001-004


Reconcile


Liechtenstein


31.8.2008




EU/2/08/080/001-004/IS


Reconcile


Iceland


5.8.2008




EU/2/08/081/001-003/IS


Posatex


Iceland


10.9.2008




EU/2/08/082/001-003


Zactran


Liechtenstein


31.8.2008




EU/2/08/082/001-003/IS


Zactran


Iceland


8.9.2008




EU/2/08/083/001


Equioxx


Liechtenstein


31.8.2008




EU/2/08/084/001/NO-005/NO


Trocoxil


Norway


15.10.2008




EU/2/08/084/001-005


Trocoxil


Liechtenstein


31.10.2008




EU/2/08/084/001-005/IS


Trocoxil


Iceland


24.10.2008




EU/2/08/085/001


Easotic


Liechtenstein


31.12.2008




EU/2/08/086/001/NO-003/NO


Duvaxyn WNV


Norway


18.12.2008




EU/2/08/086/001-003


Duvaxyn WNV


Liechtenstein


31.12.2008




EU/2/08/087/001-002


Masivet


Liechtenstein


31.12.2008




EU/2/08/087/001-002/IS


Masivet


Iceland


12.12.2008




EU/2/08/088/001-004


Acticam


Liechtenstein


31.12.2008







ANNEX II

List of renewed marketing authorisations

The following marketing authorisations have been renewed in the EEA EFTA States during the period 1 July-31 December 2008:








EU-Number


Product


Country


Date of authorisation




EU/1/00/162/003/NO-005/NO;
EU/1/00/162/009/NO-011/NO;
EU/1/00/162/015/NO-017/NO;
EU/1/00/162/019/NO-021/NO


Prandin


Norway


15.8.2008




EU/1/00/162/003-005, 009-011, 015-017, 019-021


Prandin


Liechtenstein


31.8.2008




EU/1/00/162/003-005, 009-011, 015-017, 019-021/IS


Prandin


Iceland


26.9.2008




EU/1/03/247/001/NO-002/NO


Forsteo


Norway


1.7.2008




EU/1/03/252/001/NO-003/NO


Fuzeon


Norway


12.8.2008




EU/1/03/252/001-003


Fuzeon


Liechtenstein


31.8.2008




EU/1/03/252/001-003/IS


Fuzeon


Iceland


5.8.2008




EU/1/03/254/002


Busilvex


Liechtenstein


31.8.2008




EU/1/03/254/002/IS


Busilvex


Iceland


10.7.2008




EU/1/03/254/002/NO


Busilvex


Norway


12.8.2008




EU/1/03/255/001/NO-006/NO


Ventavis


Norway


29.9.2008




EU/1/03/255/001-006


Ventavis


Liechtenstein


31.10.2008




EU/1/03/255/001-006/IS


Ventavis


Iceland


19.10.2008




EU/1/03/256/001/NO-010/NO


Humira


Norway


25.9.2008




EU/1/03/256/001-010


Humira


Liechtenstein


31.10.2008




EU/1/03/256/001-010/IS


Humira


Iceland


24.10.2008




EU/1/03/258/001/NO-022/NO


Avandamet


Norway


9.9.2008




EU/1/03/258/001-022


Avandamet


Liechtenstein


31.8.2008




EU/1/03/258/001-022/IS


Avandamet


Iceland


20.10.2008




EU/1/03/259/001/NO-006/NO


Onsenal


Norway


6.11.2008




EU/1/03/259/001-006


Onsenal


Liechtenstein


31.10.2008




EU/1/03/259/001-006/IS


Onsenal


Iceland


12.12.2008




EU/1/03/260/001/NO-023/NO


Stalevo


Norway


9.10.2008




EU/1/03/260/001-023


Stalevo


Liechtenstein


31.10.2008




EU/1/03/260/001-023/IS


Stalevo


Iceland


22.10.2008




EU/1/03/261/001/NO-003/NO


Emtriva


Norway


10.11.2008




EU/1/03/261/001-003


Emtriva


Liechtenstein


31.10.2008




EU/1/03/261/001-003/IS


Emtriva


Iceland


27.10.2008




EU/1/03/262/001/NO-008/NO


Emend


Norway


8.10.2008




EU/1/03/262/001-008


Emend


Liechtenstein


31.10.2008




EU/1/03/262/001-008/IS


Emend


Iceland


27.10.2008




EU/1/03/269/001


Faslodex


Liechtenstein


31.12.2008




EU/1/06/367/001-012


Diacomit


Liechtenstein


31.12.2008




EU/1/06/367/001-012/IS


Diacomit


Iceland


18.12.2008




EU/1/07/436/001-002


Isentress


Liechtenstein


31.12.2008




EU/1/07/436/001-002/IS


Isentress


Iceland


18.12.2008




EU/1/98/064/001


Pylobactell


Liechtenstein


31.8.2008




EU/1/98/064/001/IS


Pylobactell


Iceland


19.10.2008




EU/1/98/064/001/NO


Pylobactell


Norway


8.12.2008




EU/1/98/065/001/NO-002/NO


Optison


Norway


18.9.2008




EU/1/98/065/001-002/IS


Optison


Iceland


10.7.2008




EU/1/98/069/001a/NO-007a/NO;
EU/1/98/069/001b/NO-007b/NO
EU/1/98/069/008/NO-010/NO


Plavix


Norway


2.7.2008




EU/1/98/070/001a/NO-007a/NO;
EU/1/98/070/001b/NO-007b/NO;
EU/1/98/070/008/NO-010/NO


Iscover


Norway


2.7.2008




EU/1/98/071/001/NO-006/NO


Xenical


Norway


9.9.2008




EU/1/98/071/001-006/IS


Xenical


Iceland


10.7.2008




EU/1/98/073/001/NO-004/NO


Evista


Norway


19.9.2008




EU/1/98/073/001-004


Evista


Liechtenstein


31.8.2008




EU/1/98/073/001-004/IS


Evista


Iceland


22.10.2008




EU/1/98/074/001/NO-004/NO


Optruma


Norway


19.9.2008




EU/1/98/074/001-004


Optruma


Liechtenstein


31.8.2008




EU/1/98/074/001-004/IS


Optruma


Iceland


22.10.2008




EU/1/98/076/004/NO-006/NO,
EU/1/98/076/011/NO-013/NO,
EU/1/98/076/018/NO-020/NO,
EU/1/98/076/022/NO-024/NO


NovoNorm


Norway


15.8.2008




EU/1/98/076/004-006, 011-013, 018-020, 022-024


NovoNorm


Liechtenstein


31.8.2008




EU/1/98/076/004-006, 011-013, 018-020, 022-024/IS


NovoNorm


Iceland


25.9.2008




EU/1/98/077/002/NO-004/NO;
EU/1/98/077/006/NO-008/NO;
EU/1/98/077/010/NO-019/NO


Viagra


Norway


24.9.2008




EU/1/98/077/002-004, 006-008, 010-019/IS


Viagra


Iceland


25.10.2008




EU/1/98/080/001


Aldara


Liechtenstein


31.10.2008




EU/1/98/080/001/IS


Aldara


Iceland


19.11.2008




EU/1/98/080/001/NO


Aldara


Norway


9.10.2008




EU/1/98/081/001/NO-004/NO


Comtan


Norway


29.9.2008




EU/1/98/081/001-004


Comtan


Liechtenstein


31.10.2008




EU/1/98/081/001-004/IS


Comtan


Iceland


21.10.2008




EU/1/98/082/001/NO-003/NO;
EU/1/98/082/005/NO


Comtess


Norway


29.9.2008




EU/1/98/082/001-003, 005


Comtess


Liechtenstein


31.10.2008




EU/1/98/082/001-003, 005/IS


Comtess


Iceland


21.10.2008




EU/1/98/084/001/NO-002/NO


Simulect


Norway


11.11.2008




EU/1/98/084/001-002


Simulect


Liechtenstein


31.10.2008




EU/1/98/084/001-002/IS


Simulect


Iceland


7.11.2008




EU/1/98/085/001/NO-034/NO


Karvezide


Norway


28.10.2008




EU/1/98/085/001-034


Karvezide


Liechtenstein


31.12.2008




EU/1/98/085/001-034/IS


Karvezide


Iceland


28.10.2008




EU/1/98/086/001/NO-034/NO


CoAprovel


Norway


28.10.2008




EU/1/98/086/001-034


CoAprovel


Liechtenstein


31.12.2008




EU/1/98/086/001-034/IS


CoAprovel


Iceland


28.10.2008




EU/1/98/089/001-022


Pritor


Liechtenstein


31.12.2008




EU/1/98/089/001-022/IS


Pritor


Iceland


18.12.2008




EU/1/98/090/001-020


Micardis


Liechtenstein


31.12.2008




EU/1/98/090/001-020/IS


Micardis


Iceland


18.12.2008




EU/1/98/091/001-014


Kinzalmono


Liechtenstein


31.12.2008




EU/1/98/091/001-014/IS


Kinzalmono


Iceland


18.12.2008




EU/2/03/040/001-002/IS


Gonazon


Iceland


11.7.2008




EU/2/03/041/001-005


Draxxin


Liechtenstein


31.10.2008




EU/2/03/041/001-005/IS


Draxxin


Iceland


27.10.2008




EU/2/98/009/001/NO-006/NO


Suvaxyn Aujeszky


Norway


18.12.2008




EU/2/98/009/001-006


Suvaxyn Aujeszky


Liechtenstein


31.10.2008




EU/2/99/011/001


Locatim


Liechtenstein


31.12.2008







ANNEX III

List of extended marketing authorisations

The following marketing authorisations have been extended in the EEA EFTA States during the period 1 July-31 December 2008:








EU-Number


Product


Country


Date of authorisation




EU/1/01/183/030-032


HBVAXPRO


Liechtenstein


31.10.2008




EU/1/01/195/022-027


Liprolog


Liechtenstein


31.8.2008




EU/1/01/195/022-027/IS


Liprolog


Iceland


11.8.2008




EU/1/02/214/011/NO-015/NO


Kinzalkomb


Norway


15.9.2008




EU/1/02/215/015/NO-021/NO


PritorPlus


Norway


15.9.2008




EU/1/03/255/006


Ventavis


Liechtenstein


31.8.2008




EU/1/03/267/010


Reyataz


Liechtenstein


31.12.2008




EU/1/04/291/003


Raptiva


Liechtenstein


31.10.2008




EU/1/04/291/003/NO


Raptiva


Norway


26.11.2008




EU/1/04/305/002


Truvada


Liechtenstein


31.10.2008




EU/1/04/305/002/NO


Truvada


Norway


16.9.2008




EU/1/05/330/005/NO-011/NO


Rotarix


Norway


6.10.2008




EU/1/05/330/005-011


Rotarix


Liechtenstein


31.10.2008




EU/1/05/330/005-011/IS


Rotarix


Iceland


27.9.2008




EU/1/05/331/038/NO-055/NO


Neupro


Norway


25.9.2008




EU/1/05/331/038-055


Neupro


Liechtenstein


31.10.2008




EU/1/05/331/038-055/IS


Neupro


Iceland


15.10.2008




EU/1/06/343/006-007


Baraclude


Liechtenstein


31.8.2008




EU/1/06/356/007-009


Exjade


Liechtenstein


31.12.2008




EU/1/06/360/012


Champix


Liechtenstein


31.8.2008




EU/1/06/368/088/NO-142/NO


Insulin Human Winthrop


Norway


28.11.2008




EU/1/06/368/088-142


Insulin Human Winthrop


Liechtenstein


31.12.2008




EU/1/07/386/011-012


Toviaz


Liechtenstein


31.8.2008




EU/1/07/386/013-016


Toviaz


Liechtenstein


31.12.2008




EU/1/07/392/002


Circadin


Liechtenstein


31.8.2008




EU/1/07/394/007-009


Optaflu


Liechtenstein


31.8.2008




EU/1/07/400/017/NO-021/NO


Mircera


Norway


13.10.2008




EU/1/07/400/017-020/IS


Mircera


Iceland


17.10.2008




EU/1/07/400/017-021


Mircera


Liechtenstein


31.10.2008




EU/1/07/410/017-020


Binocrit


Liechtenstein


31.8.2008




EU/1/07/411/017-020


Epoetin alfa Hexal


Liechtenstein


31.8.2008




EU/1/07/412/017-020


Abseamed


Liechtenstein


31.8.2008




EU/1/07/414/018


Galvus


Liechtenstein


31.10.2008




EU/1/07/419/010-012


Cervarix


Liechtenstein


31.12.2008




EU/1/07/431/020/NO-025/NO


Retacrit


Norway


15.12.2008




EU/1/07/431/020-025


Retacrit


Liechtenstein


31.12.2008




EU/1/07/432/020-022


Silapo


Liechtenstein


31.8.2008




EU/1/95/003/007/NO-008/NO


Betaferon


Norway


13.11.2008




EU/1/95/003/007-008


Betaferon


Liechtenstein


31.12.2008




EU/1/97/030/140/NO-169/NO


Insuman


Norway


1.12.2008




EU/1/97/030/140-169


Insuman


Liechtenstein


31.12.2008




EU/102/206/021/NO-035/NO


Arixtra


Norway


8.9.2008




EU/102/206/021-035


Arixtra


Liechtenstein


31.10.2008




EU/2/02/033/002


Dexdomitor


Liechtenstein


31.8.2008




EU/2/05/054/018/NO-031/NO


Profender


Norway


24.9.2008




EU/2/05/054/018-031


Profender


Liechtenstein


31.10.2008




EU/2/05/054/018-031/IS


Profender


Iceland


1.10.2008




EU/2/06/058/004


Flexicam


Liechtenstein


31.12.2008




EU/2/99/015/002


Oxyglobin


Liechtenstein


31.10.2008







ANNEX IV

List of withdrawn marketing authorisations

The following marketing authorisations have been withdrawn in the EEA EFTA States during the period 1 July-31 December 2008:








EU-Number


Product


Country


Date of withdrawal




EU/1/01/184/001-073


Nespo


Liechtenstein


31.12.2008




EU/1/01/185/023-030


Aranesp


Liechtenstein


31.12.2008




EU/1/02/202/001-006


Protopy


Liechtenstein


31.10.2008




EU/1/02/202/001-006/IS


Protopy


Iceland


27.9.2008




EU/1/02/228/001-003


Neupopeg


Liechtenstein


31.12.2008




EU/1/04/293/001-012


Parareg


Liechtenstein


31.12.2008




EU/1/04/301/001/NO-005/NO


Quintanrix


Norway


25.11.2008




EU/1/04/301/001-005


Quintanrix


Liechtenstein


31.10.2008




EU/1/04/301/001-005/IS


Quintanrix


Iceland


27.9.2008




EU/1/05/327/001/NO-018/NO


Exubera


Norway


25.11.2008




EU/1/05/327/001-018


Exubera


Liechtenstein


31.10.2008




EU/1/05/327/001-018/IS


Exubera


Iceland


22.10.2008




EU/1/98/093/002


Forcaltonin


Liechtenstein


31.12.2008




EU/1/98/093/002/IS


Forcaltonin


Iceland


29.11.2008




EU/1/98/093/002/NO


Forcaltonin


Norway


25.11.2008




EU/1/99/128/001/NO-037/NO


Viraferon


Norway


29.10.2008




EU/1/99/128/001-037


Viraferon


Liechtenstein


31.10.2008




EU/1/99/128/001-037/IS


Viraferon


Iceland


22.10.2008







ANNEX V

List of suspended marketing authorisations

The following marketing authorisations have been suspended in the EEA EFTA States during the period 1 July-31 December 2008:








EU-Number


Product


Country


Date of suspension




EU/1/06/344/001-011


Acomplia


Liechtenstein


31.12.2008




EU/1/06/344/001-011/IS


Acomplia


Iceland


26.11.2008




EU/1/06/345/001-011


Zimulti


Liechtenstein


31.12.2008




EU/1/06/345/001-011/IS


Zimulti


Iceland


26.11.2008